- Bezafibrate and simvastatin combination therapy for diabetic dyslipidaemia: efficacy and safety - (https://pubmed.ncbi.nlm.nih.gov/10809995/ )
- Bezafibrate may attenuate biliary damage associated with chronic liver diseases accompanied by high serum biliary enzyme levels - (https://pubmed.ncbi.nlm.nih.gov/16933007/ )
- Bezafibrate reduces heart rate and blood pressure in patients with hypertriglyceridemia - (https://pubmed.ncbi.nlm.nih.gov/11330878/ )
- Bezafibrate reduces blood glucose in type 2 diabetes mellitus - (https://pubmed.ncbi.nlm.nih.gov/10726910/ )
- Acute severe myositis due to bezafibrate treatment - (https://pubmed.ncbi.nlm.nih.gov/2722079/ )
Bezafibrate (Bezalip (400mg)) is a fibrate drug, prescribed for high cholesterol in blood.It works mainly by stimulating the action of two enzymes.
The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak with a healthcare professional.
Bezalip (400mg) - AHPL
Bezalip (400mg) Tablet
Generic : Bezafibrate
Substitute/Alternative Medication to Bezalip (400mg)
When is Bezalip (400mg) prescribed?
It is prescribed for -